Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AMN · against 435 other Healthcare companies of similar size
Ranked #44 of 436 · scores higher than 90% of peers
Bars: peers in each 10-point band of the valuation score60 peers with a valuation score of 80–89, including AMN · Click a bar to see the companies
Mainly thanks to its free cash flow yield, EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | AMN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 425 reported | 5.9% | 1.7% | 82% | 30% | |
| EBITDA yieldHigher is better · 435 reported | 14.2% | 4.4% | 92% | 50% | |
| Free cash flow yieldHigher is better · 200 reported | 25.0% | -0.5% | 99% | 20% | |
| Book yieldHigher is better · 427 reported | 42.3% | 36.2% | 59% | Context only |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score